Empire State Development (ESD) today announced that Global NY will lead a trade mission to Medtec China, the leading medical device design and manufacturing exhibition in China, from September 25-27 in Shanghai. Global NY is recruiting up to 10 New York State small businesses interested in exporting to this key global market that is seeking high-tech products and services from New York companies. The application deadline is May 31. Global NY offers one-stop shopping to both local businesses that want to export globally and to foreign businesses looking to invest in New York. Empire State Development President, CEO and Commissioner Howard Zemsky said, “New York is a global leader across many innovative industries, and the state’s medical supply businesses should take advantage of this opportunity to connect and export to this large and easily accessible market.” Medtec China 2019, a premier manufacturing and sourcing event for medical device manufacturers, will take place at the Shanghai World EXPO Exhibition & Convention Centre. Key industries include assembly equipment and production machinery, packaging, sterilization and cleanroom equipment, plastics/disposable devices and diagnostics, precision technology, medical electronics and more. Eligible businesses can receive reimbursement from Global NY’s State Trade Expansion Program (STEP) for travel and lodging expenses. STEP is a Global NY program that is funded in part through a grant from the U.S. Small Business Administration (SBA) to increase the number of businesses entering the export market, and to increase the value of exports businesses are already producing. Grants are offered to qualifying small and medium-sized businesses for a range of purposes, including participation in foreign trade shows like Medtec China 2019. Companies are also eligible to apply for Global NY’s customized Export Marketing Assistance Service (EMAS) in China. Global NY organizes trade missions each year to help New York’s small to mid-sized companies export overseas as well as encourage foreign companies to invest and grow their businesses in the state. In 2018, Global NY led 37 companies on trade missions to Mexico, Germany, Canada and China. China is currently New York’s second-largest buyer, and the United States’ third-largest export market. New York exported approximately $12.6 billion in goods to China in 2018. To apply for the trade mission, contact Global NY at globalny@esd.ny.gov or 212-803-2300. To learn more about Global NY, click here. About Empire State Development Empire State Development (ESD) is New York’s chief economic development agency (www.esd.ny.gov). The mission of ESD is to promote a vigorous and growing economy, encourage the creation of new job and economic opportunities, increase revenues to the State and its municipalities, and achieve stable and diversified local economies. Through the use of loans, grants, tax credits and other forms of financial assistance, ESD strives to enhance private business investment and growth to spur job creation and support prosperous communities across New York State. ESD is also the primary administrative agency overseeing Governor Cuomo’s Regional Economic Development Councils and the marketing of “I LOVE NEW YORK,” the State’s iconic tourism brand. For more information on Regional Councils and Empire State Development, visit www.regionalcouncils.ny.gov and www.esd.ny.gov.   Contact: Adam Kilduff | adam.kilduff@esd.ny.gov | (212) 803-3744 ESD Press Office | pressoffice@esd.ny.gov | (800) 260-7313

Universal Stainless & Alloy Products Capital Project

Wayfair Zenker Drive Capital Project

Governor Andrew M. Cuomo today announced a $5 million grant that will allow NeuroCuresNY, Inc. to conduct a two-year demonstration of its unique clinical trial network and process for testing drugs to treat disability due to neurological impairment. NCNY, a not-for-profit initiative formed by Burke Neurological Institute, the University of Rochester and the Wadsworth Center to conduct clinical trials of drugs for chronic neurological impairment and disability, aims to reduce the time and cost of drug development for patients disabled from stroke who have exhausted everything that the health care system currently offers. The grant is part of New York State's $620 million Life Science Initiative to spur the growth of a world-class life science research cluster in New York, as well as expand the state's ability to commercialize this research and grow the economy. "Building a healthier future for New York means leading the way on critical scientific research and development projects today," Governor Cuomo said. "NeuroCuresNY's demonstration trial will test innovative new drugs and therapies that have the potential to make a world of difference for patients suffering from the effects of stroke and continue New York's unprecedented growth in the life sciences industry."  "The life sciences industry continues to grow across the state thanks to investments in cutting edge research and development," said Lieutenant Governor Kathy Hochul. "This funding will provide the resources needed to help find a cure for neurological impairments that result from a stroke. The grant for NeuroCuresNY builds on our commitment to support innovative studies and treatments to ensure the health and well-being of all New Yorkers." The demonstration trial will combine the use of medication to repair the brain in combination with robotic training technology, which can re-educate the individual's nervous system. The two-year trial will require over 150 patients with chronic disability due to stroke and will run for approximately 24 months. Over time, NCNY plans to evaluate treatments for disability due to other neurological conditions such as brain injury, Alzheimer's disease and spinal cord injury. Read the complete press release here.